HomeProduct Newsletters > Shengke Biopharma to build 5,000 t/a capacity for N-(4-Aminobenzoyl)-L-glutamic acid Read online

Shengke Biopharma to build 5,000 t/a capacity for N-(4-Aminobenzoyl)-L-glutamic acid

On 28 March, the environmental impact (EI) report of N-(4-Aminobenzoyl)-L-glutamic acid project from Guangxi Shengke Biopharmaceutical Co., Ltd. (Shengke Biopharma) was accepted and published by local authority.Project overviewType of project: new co...

Amino Acids China E-News 202404

www.cnchemicals.com